Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.16 Bil Enterprise Value: 9.58 Bil PE Ratio: 106.36 PB Ratio: 2.73 GF Score: 85/100

Qiagen NV at Stifel Healthcare Conference Transcript

Nov 14, 2023 / 04:30PM GMT
Release Date Price: €37.56 (+1.66%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay everybody. Welcome back to the 2023 Stifel Healthcare Conference on the Life Sciences and Diagnostics track here, and I'm happy to have CEO, Thierry Bernard from QIAGEN with us. Thierry thanks for joining us.

Thierry Bernard
Qiagen N.V. - CEO, MD & Member of Management Board

Good morning. Thank you.

Questions & Answers

Daniel Anthony Arias;Thierry Bernard
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst;Qiagen N.V. - CEO, MD & Member of

Our pleasure. Maybe a place to start, which I've been doing with some of our companies here is just sort of recap the last quarter, 5% CER growth for the nonbusiness this quarter was outside of 1 or 2 players, the highest in the core tools group, I think it's worth noting. Can you just maybe talk where the relative strength in the business is today on the non-COVID side?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot